CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Postpartum depression affects many new mothers, increasing suicide risk. New research shows preventive cognitive behavioral ...
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...
Verywell Health on MSN1d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionFact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, ...
Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...
ScienceAlert on MSN6d
FDA-Approved Nasal Spray For Depression Is First Of Its KindA ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...
The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback